These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28495132

  • 1. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
    Sauer EL, Trifilieff E, Greer JM.
    J Neuroimmunol; 2017 Jun 15; 307():18-26. PubMed ID: 28495132
    [Abstract] [Full Text] [Related]

  • 2. Encephalitogenicity of murine, but not bovine, DM20 in SJL mice is due to a single amino acid difference in the immunodominant encephalitogenic epitope.
    Greer JM, Klinguer C, Trifilieff E, Sobel RA, Lees MB.
    Neurochem Res; 1997 Apr 15; 22(4):541-7. PubMed ID: 9130268
    [Abstract] [Full Text] [Related]

  • 3. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
    Mendel Kerlero de Rosbo N, Ben-Nun A.
    Eur J Immunol; 1996 Oct 15; 26(10):2470-9. PubMed ID: 8898962
    [Abstract] [Full Text] [Related]

  • 4. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK, Thomas DM.
    J Neuroimmunol; 1995 Feb 15; 56(2):161-70. PubMed ID: 7532182
    [Abstract] [Full Text] [Related]

  • 5. Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice.
    Heijmans N, Smith PA, Morris-Downes MM, Pryce G, Baker D, Donaldson AV, 't Hart B, Amor S.
    J Neuroimmunol; 2005 Oct 15; 167(1-2):23-33. PubMed ID: 16054237
    [Abstract] [Full Text] [Related]

  • 6. Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein.
    Sun D, Le J, Coleclough C.
    Eur J Immunol; 1993 Feb 15; 23(2):494-8. PubMed ID: 7679647
    [Abstract] [Full Text] [Related]

  • 7. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF, Vandenbark AA, Offner H.
    J Neurosci Res; 1996 Sep 15; 45(6):680-9. PubMed ID: 8892079
    [Abstract] [Full Text] [Related]

  • 8. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J, Subramanian S, Jones R, Rich C, Link J, Mooney J, Bourdette DN, Vandenbark AA, Burrows GG, Offner H.
    J Immunol; 2004 Apr 01; 172(7):4556-66. PubMed ID: 15034073
    [Abstract] [Full Text] [Related]

  • 9. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H, Zhang H, Liu F, Qi Y, Jiang H.
    Immunol Lett; 2014 Apr 01; 157(1-2):38-44. PubMed ID: 24220208
    [Abstract] [Full Text] [Related]

  • 10. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA, Kuchroo VK.
    J Immunol; 1992 Aug 15; 149(4):1444-51. PubMed ID: 1380045
    [Abstract] [Full Text] [Related]

  • 11. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK, Kannarkat GT, Chung J, Joon Lee H, Graham KL, Tansey MG.
    J Neuroinflammation; 2016 Feb 01; 13():24. PubMed ID: 26831924
    [Abstract] [Full Text] [Related]

  • 12. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I, Keller CW, Weber P, Schneider C, von Gunten S, Lünemann JD.
    J Neuroinflammation; 2016 Feb 18; 13():42. PubMed ID: 26893156
    [Abstract] [Full Text] [Related]

  • 13. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides.
    Falk K, Rötzschke O, Santambrogio L, Dorf ME, Brosnan C, Strominger JL.
    J Exp Med; 2000 Feb 21; 191(4):717-30. PubMed ID: 10684863
    [Abstract] [Full Text] [Related]

  • 14. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C, Ciric B, Yu S, Zhang GX, Rostami A.
    J Neuroimmunol; 2016 Feb 15; 291():59-69. PubMed ID: 26857496
    [Abstract] [Full Text] [Related]

  • 15. Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide(91-110) and critical residues required for induction of EAE in HLA-DR3 transgenic mice.
    Mangalam AK, Khare M, Krco CJ, Rodriguez M, David CS.
    J Neuroimmunol; 2005 Apr 15; 161(1-2):40-8. PubMed ID: 15748942
    [Abstract] [Full Text] [Related]

  • 16. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice.
    Kaushansky N, Zhong MC, Kerlero de Rosbo N, Hoeftberger R, Lassmann H, Ben-Nun A.
    J Immunol; 2006 Nov 15; 177(10):7364-76. PubMed ID: 17082656
    [Abstract] [Full Text] [Related]

  • 17. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH, Kotzin BL, Buenafe AC, Weinberg AD, Jones RE, Hashim GA, Hoy CM, Vandenbark AA, Offner H.
    J Neurosci Res; 1993 Jun 01; 35(2):115-28. PubMed ID: 7686583
    [Abstract] [Full Text] [Related]

  • 18. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
    Wegmann KW, Archie Bouwer HG, Whitham RH, Hinrichs DJ.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):46-52. PubMed ID: 24997489
    [Abstract] [Full Text] [Related]

  • 19. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S, Alexander J, Bronson R, Carroll J, Southwood S, Dorf M.
    J Immunol; 1995 Jan 01; 154(1):388-98. PubMed ID: 7527816
    [Abstract] [Full Text] [Related]

  • 20. Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.
    McDonald CA, Payne NL, Sun G, Clayton DJ, Del Borgo MP, Aguilar MI, Perlmutter P, Bernard CC.
    J Neuroimmunol; 2014 Dec 15; 277(1-2):67-76. PubMed ID: 25454728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.